Cardiac Implant Market, by Device (Pacemaker Devices, Cardiac Resynchronization Therapy Devices, Implantable Hemodynamic Monitoring Devices, Implanted Heart Rhythm Monitors, Coronary Stents, Implantable Cardioverter Defibrillator, Heart Valve, and Others)

Cardiac Implant Market, by Device (Pacemaker Devices, Cardiac Resynchronization Therapy Devices, Implantable Hemodynamic Monitoring Devices, Implanted Heart Rhythm Monitors, Coronary Stents, Implantable Cardioverter Defibrillator, Heart Valve, and Others), by Application (Arrhythmias, Myocardial Ischemia, Acute Myocardial Infraction, Congestive Heart Failure, and Others), by End User (Hospitals, Emergency Medical Centers, Ambulatory Surgical Center, Home Care Settings, and Others) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Trends, and Forecast 2018 - 2027

An implantable cardiac devices is used to regulate and detect irregular heartbeat. The implantable cardiac device includes biventricular pacemakers, pacemakers, implantable cardioverter defibrillator (ICD), and cardiac loop recorders. Biomaterial used in manufacturing cardiac implants are biocreamics, polymers, composite materials, metals and their alloys. The implantable cardioverter-defibrillator is categorized into two types namely traditional ICD and subcutaneous ICD (S-ICD). There are eight types of U.S. Food and Drug Administration (U.S. FDA) approved devices that treat the heart disorders such as automated external defibrillators (AEDs), cardiac ablation catheters, cardiovascular angioplasty devices, cardiac pacemakers, implantable cardioverter defibrillators (ICDs), prosthetic (artificial) heart valves, stents, ventricular assist devices (VADs). Cardiac implantable electric device such as pacemakers, implantable cardioverter defibrillators (ICDs), and cardiac resynchronization therapy (CRT) devices are extensively used for cardiac disorders. Furthermore, there are two types of pacemakers used single chamber pacemaker and dual-chamber pacemaker.

Market Dynamics

Key players operating in cardiac implants market are launching new products based on advanced technologies, which is contributing to growth of the cardiac implants market. For instance, in April 2022, MicroPort CRM, a China-based cardiac rhythm management announced that it received MRI-conditional CE mark approval from the European Union for its Ulys and Edis ICDs. These new ICDs are high-voltage devices incorporated with advanced technology which allows low current consumption, resulting in long lifespan of the devices. The increasing efforts and innovative technologies are seen to emerge new strategy for driving the market. Hence, the launch of the advanced cardiac implants is expected to drive the market growth over the forecast period.

Key features of the study:

• This report provides an in-depth analysis of the global cardiac implants market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022–2030), considering 2021 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global cardiac implants market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, strategies
• Key companies covered as a part of this study include Abbott Laboratories, B. Braun Melsungen AG, Boston Scientific Corporation, Edwards Lifesciences Corporation, Meril Life Sciences Pvt. Ltd., Lepu Medical Technology (Beijing) Co., Ltd., BIOTRONIK SE & Co. KG, OSYPKA MEDICAL, Pacetronix.com, Vitatron, Terumo Corporation, Cordis, MicroPort Scientific Corporation.
• Global cardiac implants market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have an ease in decision-making through various strategy matrices used in analysing the global cardiac implants market

Detailed Segmentation:

• Global Cardiac Implants Market, By Device Type
• Pacemaker Devices
• Cardiac Resynchronization Therapy Devices
• Implantable Hemodynamic Monitoring Devices
• Implanted Heart Rhythm Monitors
• Coronary Stents
• Implantable Cardioverter Defibrillator
• Heart Valve
• Others
• Global Cardiac Implants Market, By Application
• Arrhythmias
• Myocardial Ischemia
• Acute Myocardial Infraction
• Congestive Heart Failure
• Others
• Global Cardiac Implants Market, By End User
• Hospitals
• Specialty Clinics
• Others
• Others Global Cardiac Implants Market, By Region:
• North America
• By Country
• U.S.
• Canada
• Latin America
• By Country
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
• By Country
• Germany
• U.K.
• France
• Italy
• Spain
• Russia
• Rest of Europe
• Asia Pacific
• By Country
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Middle East
• By Country
• GCC
• Israel
• Rest of Middle East
• Africa
• By Country/Region
• South Africa
• Central Africa
• North Africa
• Company Profiles
• Abbott Laboratories*
• Company Highlights
• Products Portfolio
• Key Highlights
• Financial Performance
• Strategies
• B. Braun Melsungen AG
• Boston Scientific Corporation
• Edwards Lifesciences Corporation
• Meril Life Sciences Pvt. Ltd.
• Lepu Medical Technology (Beijing) Co. Ltd.
• BIOTRONIK SE & Co. KG
• OSYPKA MEDICAL
• Pacetronix.com
• Vitatron
• Terumo Corporation
• Cordis
• MicroPort Scientific Corporation

“*” marked represents similar segmentation in other categories in the respective section.